← Back to Screener
Bio Green Med Solution, Inc. Common Stock (BGMS)
Price$1.19
Favorite Metrics
Price vs S&P 500 (26W)-86.97%
Price vs S&P 500 (4W)6.90%
Market Capitalization$6.54M
All Metrics
Book Value / Share (Quarterly)$1.27
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.88
Price vs S&P 500 (YTD)-23.86%
Gross Margin (TTM)18.47%
Net Profit Margin (TTM)-214.06%
EPS (TTM)$-1.86
10-Day Avg Trading Volume0.19M
EPS Excl Extra (TTM)$-1.86
EPS (Annual)$-1.37
Dividend / Share (Annual)$0.02
ROI (Annual)-43.82%
Gross Margin (Annual)18.47%
Net Profit Margin (5Y Avg)-7621.91%
Cash / Share (Quarterly)$0.65
Revenue Growth QoQ (YoY)710.00%
ROA (Last FY)-36.63%
Revenue Growth TTM (YoY)1637.21%
EBITD / Share (TTM)$-1.97
ROE (5Y Avg)-788.35%
Operating Margin (TTM)-277.64%
Cash Flow / Share (Annual)$-0.88
P/B Ratio0.96x
P/B Ratio (Quarterly)1.06x
Net Interest Coverage (TTM)-284.57x
ROA (TTM)-48.99%
EPS Incl Extra (Annual)$-1.37
Current Ratio (Annual)4.70x
Quick Ratio (Quarterly)3.66x
3-Month Avg Trading Volume0.10M
52-Week Price Return-97.82%
P/S Ratio (Annual)8.76x
Asset Turnover (Annual)0.09x
52-Week High$100.80
Operating Margin (5Y Avg)-8498.71%
EPS Excl Extra (Annual)$-1.37
26-Week Price Return-80.08%
Quick Ratio (Annual)3.66x
13-Week Price Return-17.13%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.70x
Enterprise Value$3.036
Asset Turnover (TTM)0.09x
Inventory Turnover (Annual)1.67x
Pretax Margin (Annual)-400.40%
Cash / Share (Annual)$0.65
3-Month Return Std Dev102.64%
Gross Margin (5Y Avg)62.05%
ROE (Last FY)-43.82%
Net Interest Coverage (Annual)-110.66x
EPS Basic Excl Extra (Annual)$-1.37
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.86
ROI (TTM)-58.13%
Dividend Growth Rate (5Y)-39.23%
P/S Ratio (TTM)8.76x
Pretax Margin (5Y Avg)-8353.92%
Revenue / Share (Annual)$0.34
Price vs S&P 500 (52W)-132.45%
Year-to-Date Return-19.93%
5-Day Price Return13.94%
EPS Normalized (Annual)$-1.37
ROA (5Y Avg)-137.62%
Net Profit Margin (Annual)-401.34%
Month-to-Date Return18.50%
EBITD / Share (Annual)$-1.43
Operating Margin (Annual)-465.86%
ROI (5Y Avg)-788.35%
EPS Basic Excl Extra (TTM)$-1.86
P/B Ratio (Annual)1.06x
Dividend / Share (TTM)$0.02
Inventory Turnover (TTM)3.39x
Pretax Margin (TTM)-213.39%
Book Value / Share (Annual)$1.27
Price vs S&P 500 (13W)-19.51%
Dividend Yield (TTM)0.93%
Beta-0.31x
Revenue / Share (TTM)$0.34
ROE (TTM)-58.13%
52-Week Low$0.73
Analyst Recommendations
Nov 2024
Dec 2024
Jan 2025
Feb 2025
4.13
2.17
2.17
2.17
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
BGMSBio Green Med Solution, Inc. Common Stock | 8.76x | 1637.21% | 18.47% | — | $1.19 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company developing targeted cancer therapies through CDK and PLK inhibitor programs, including lead candidates fadraciclib and plogosertib. The company addresses proliferative diseases by targeting cell cycle pathways and operates from the United Kingdom.